Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe
New Articles
Scientists can now differentiate between healthy cells and cancer cells 1/6/2009

'Relocation' plan of metastatic cancer cells uncovered 1/6/2009

Genetic variation may lead to early cardiovascular disease 1/5/2009

Scientists closing the zap on dengue fever 1/4/2009

Dormant cancer cells rely on cellular self-cannibalization to survive 1/4/2009

Toxicity mechanism identified for Parkinson's disease 1/4/2009

Molecular imaging enables earlier, individualized treatment of thyroid cancer 1/3/2009

Arousal frequency in heart failure found to be a unique sleep problem 1/3/2009

Researchers engineer pancreatic cell transplants to evade immune response 1/2/2009

A new light on the anti-tumor mechanisms of Scutellaria barbata 1/2/2009

Few DNA repair genes maintain association with cancer in field synopsis 1/2/2009

Scientists isolate genes that made 1918 flu lethal 1/2/2009

Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds 1/1/2009

In lung cancer, silencing one crucial gene disrupts normal functioning of genome 1/1/2009

Scientists pull protein's tail to curtail cancer 1/1/2009

Scientists use old enemy to K.O. cancer (8/14/2008)

Tags:
cancer

Chemists are pulling cancer onto a sucker punch by getting infected cells to drop their guard – according to research published today. They are using the metal ruthenium as a catalyst to a cancer-busting reaction which calls up an old cellular enemy – oxidants – as an ally.

Cancer adapts quickly to traditional drugs which attack infected cells directly. But the latest laboratory tests reveal a second line of defence using ruthenium as a catalyst to a reaction which stops cells developing the anti-oxidant chemical glutathione.

As the targeted cell is forced to drop its glutathione defences, the oxidant levels increase, and the cancerous cell dies.

University of Warwick Chemistry Professor Peter Sadler explained: "We know oxidants produce free radicals that damage cells. Our experiments show ruthenium produces a reaction in the cell which destroys its anti-oxidant defence glutathione – thus destroying the cancer-infected cell.

"Working with colleagues in Edinburgh University and Oncosense we've proved this could be an effective line of defence against cancer."

Scientists working on the project now hope to move the research out of the laboratory – the next stage for this work would be medical trials.

Note: This story has been adapted from a news release issued by the University of Warwick

Internet Marketing - United Specialties - Renegade Motorhomes - Credit Cards

Post Comments:

Search

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2010 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer